SCHEMBL11903492

SCHEMBL11903492

COc1cccc(-c2nc3ccc(OC(F)(F)F)cc3[nH]2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.66
RAB9A P51151 4/20 0.66
TP53 P04637 3/20 0.66
HPGD P15428 3/20 0.66
POLB P06746 3/20 0.66
MEN1 O00255 2/20 0.66
PKM P14618 2/20 0.66
KMT2A Q03164 2/20 0.66
HTT P42858 1/20 0.66
ALDH1A1 P00352 3/20 0.66
SMN1; SMN2 Q16637 3/20 0.66
KDM4E B2RXH2 2/20 0.66
TSHR P16473 1/20 0.66
NFKB1 P19838 1/20 0.66
NFKB2 Q00653 1/20 0.66
RELA Q04206 1/20 0.66
HSD17B10 Q99714 1/20 0.66
TRPV1 Q8NER1 1/20 0.63
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11903487 0.90 CYP1A2 (0.54) NPC1RAB9ATP53HPGDPOLB
SCHEMBL11903652 0.87 TRPV1 (0.77) NPC1RAB9ATP53HPGDPOLB
SCHEMBL11903481 0.84 TRPV1 (0.72) NPC1RAB9ATP53HPGDMEN1
SCHEMBL19970739 0.83 CYP1A2 (0.60) NPC1RAB9AHPGDPKMHTT
SCHEMBL19970744 0.81 CYP1A2 (0.60) TRPV1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL13329870 0.81 NPC1 (0.66) NPC1RAB9ATP53HPGDPOLB
SCHEMBL11903509 0.81 RUNX1 (0.70) NPC1RAB9ATP53HPGDPOLB
SCHEMBL20445328 0.80 NPC1 (1.00) NPC1RAB9ATP53HPGDPOLB
SCHEMBL11903521 0.80 RUNX1 (0.63) NPC1RAB9ATP53HPGDPOLB
SCHEMBL11903498 0.80 TRPV1 (0.77) NPC1RAB9ATP53HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8293780-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making U.S. DEPARTMENT OF ENERGY (US) 2012-10-23 US disclosed
US-8242284-B1 Anti-cancer agents based on 6-trifluoromethoxybenzimidazole derivatives and method of making THE UNITED STATES OF AMERICA AS REPRESENTED BY THE UNITED STATES DEPARTMENT OF ENERGY (US) 2012-08-14 US disclosed